---
title: "Cryo-Cell International, Inc. (CCEL.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CCEL.US.md"
symbol: "CCEL.US"
name: "Cryo-Cell International, Inc."
industry: "医疗服务"
---

# Cryo-Cell International, Inc. (CCEL.US)

| Item | Detail |
|------|--------|
| Industry | 医疗服务 |
| Location | 美股市场 |
| Website | [www.cryo-cell.com](https://www.cryo-cell.com) |

## Company Profile

Cryo-Cell International, Inc. 从事细胞处理和低温细胞存储，专注于收集和保存脐带血干细胞以供家庭使用。它提供脐带组织服务，存储一段脐带组织，这是一种间充质干细胞的来源，广泛用于再生医学以治疗多种疾病。该公司制造并销售 PrepaCyte CB 处理系统，这是一种用于处理脐带血干细胞的技术

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-27T04:30:17.000Z

**Overall: D (0.64)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 72 / 85 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.29% |  |
| Net Profit YoY | 94.69% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -1.85 |  |
| Dividend Ratio | 11.73% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 27.47M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 31.75M |  |


**Multi Score**: D

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.88% | C |
| Profit Margin | -1.49% | D |
| Gross Margin | 76.98% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.29% | D |
| Net Profit YoY | 94.69% | A |
| Total Assets YoY | 0.37% | C |
| Net Assets YoY | -55.16% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -6703.91% | E |
| OCF YoY | -0.29% | D |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.50 | C |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 123.48% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Cryo-Cell International, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.88%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "-1.49%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "76.98%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.29%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "94.69%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.37%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-55.16%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-6703.91%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-0.29%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.50",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "123.48%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | 信诺保险 (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 04 | 实验美控 (US.LH) | B | C | B | C | B | B |
| 05 | 奎斯特诊疗 (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -58.00 | 64/79 | 325.90 | 312.09 | 129.65 |
| PB | -1.85 | 63/79 | - | - | - |
| PS (TTM) | 0.87 | 27/79 | 1.31 | 1.18 | 0.95 |
| Dividend Yield | 11.73% | 1/79 | 14.48% | 12.77% | 9.98% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-10-20T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.41 |

## References

- [Company Overview](https://longbridge.com/en/quote/CCEL.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CCEL.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CCEL.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.